Fig. 2.

Overview of Study Design. Patient “a” has early AKI recovery within 48 hours (h) after AKI but after first 24 h, so intravenous (IV) fluids given within first 24h were included, Patient “b” has early AKI recovery within 24 hours (h) after AKI, so IV fluids given till early AKI recovery were included; Patient “c” did not have early AKI recovery, so IV fluids given within first 24h were included; MAKE - Major Adverse Kidney Event